Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

Greenwich LifeSciences Announces Suspension of Share Repurchase Program


Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, announced that its Board of Directors has suspended the Company's previously announced share repurchase program.

Under the now suspended share repurchase program, the Company repurchased approximately 520,000 shares of common stock for an aggregate purchase price of approximately $7.5 million. Following these repurchases, the Company had approximately 12.8 million shares of common stock outstanding.


These press releases may also interest you

at 08:42
Innovative E-Liquid Brand DELICIU Debuts Alongside VAPORESSO XROS 4 at the Vaper Expo UK
In a move that aligns with the growing concerns over disposable vapes, the innovative e-liquid brand DELICIU made its debut at the Vaper Expo UK on May 10th. This launch is especially timely, as the UK and several European countries are considering...

at 08:40
Cell and Gene Therapies in CNS Disorders Research Report 2024: Pricing and Reimbursement Assessment, Current Treatment Options, Likelihood of Approval and Phase, Future Sales - Forecasts to 2029 - ResearchAndMarkets.com
The "Cell and Gene Therapies in CNS Disorders" report has been added to ResearchAndMarkets.com's offering. The analyst anticipates that the global CGT market value in CNS disorders will experience significant growth - sales are expected to increase...

at 08:38
New Book Shares One Woman's Inspirational Journey from Prison to Personal and Professional Success
On September 23, 2007, Dr. Shanea Clancy's life took a dramatic turn, when at 21 years of age, she found herself embroiled in a nationally covered, unprecedented EMS case where she was driving an ambulance that was involved in a crash that killed two...

at 08:32
EO Welcomes New Chief Executive Officer, Dave Parker
Serial entrepreneur and board member Dave Parker has joined the Entrepreneurs' Organization (EO) as its next Chief Executive Officer. The Seattle, U.S.-based leader brings more than three decades of experience as both founder and board director for...

at 08:30
Servotronics Announces Improved First Quarter 2024 Financial Results
Servotronics, Inc. , a designer and manufacturer of servo-control components and other advanced technology products, today reported financial results for the first quarter ended March 31, 2024....

at 08:30
ePlus Honored as Growth Partner of the Year by Varonis
ePlus inc. today announced that it has been named Growth Partner of the Year by Varonis. ePlus was selected because of its demonstrated ability to leverage its deep knowledge of Varonis technology while helping organizations maximize the value from...

More news about Science and technology...


News published on and distributed by: